Healthcare

Biotechnology firm Ocugen has completed patient enrollment for the pivotal Phase 3 clinical trial of its lead candidate, OCU400, a...

Danaher Corporation has outlined a definitive strategic roadmap targeting the 2026 fiscal year. While acknowledging specific regional headwinds, the company's...

Intuitive Surgical, a leader in robotic-assisted surgery, is strategically refining its operational footprint to navigate a shifting competitive landscape. The...

The healthcare giant Johnson & Johnson is pursuing a dual strategy to enhance patient access and advance its pipeline. In...

A significant legal case commenced in Chicago on March 4, targeting global healthcare company Abbott Laboratories. The core of the...

With a notable absence of recent company-specific announcements, Animalcare's stock is currently trading in a quiet phase. This lack of...

Biopharmaceutical firm Ocugen has achieved a significant clinical development goal just two days before its annual financial report. Company leadership...

For the first time in ten years, UnitedHealth Group is forecasting a drop in revenue, marking a significant inflection point...

NRx Pharmaceuticals is bolstering its executive team with a strategic hire aimed at accelerating the development of novel neuroplastic treatments....

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor...